Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Joseph Melenhorst

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Haematologica|December 3, 2011
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantationJan Joseph Melenhorst, Xin Tian, Dihua Xu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor marginsMatthew M Grabowski, Dionysios C Watson, Kunho Chung, et al.
Critical Care Medicine|February 15, 2020
Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary SepsisJane E Whitney, Binqing Zhang, Natalka Koterba, et al.
Shock (Augusta, Ga.)|January 23, 2022
Temperature Trajectory Sub-phenotypes and the Immuno-Inflammatory Response in Pediatric SepsisNadir Yehya, Julie C Fitzgerald, Katie Hayes, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
Medcomm|January 8, 2026
Mastering Organoid Growth: A Complete Guide to Overcoming Methodological ChallengesChunbao Jiao, Omer Faruk Karakaya, Neda Dadgar, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.
Frontiers in Oncology|May 24, 2021
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent GlioblastomaJoseph S Durgin, Fraser Henderson, MacLean P Nasrallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Haematologica|December 3, 2011
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantationJan Joseph Melenhorst, Xin Tian, Dihua Xu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor marginsMatthew M Grabowski, Dionysios C Watson, Kunho Chung, et al.
Critical Care Medicine|February 15, 2020
Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary SepsisJane E Whitney, Binqing Zhang, Natalka Koterba, et al.
Shock (Augusta, Ga.)|January 23, 2022
Temperature Trajectory Sub-phenotypes and the Immuno-Inflammatory Response in Pediatric SepsisNadir Yehya, Julie C Fitzgerald, Katie Hayes, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
Medcomm|January 8, 2026
Mastering Organoid Growth: A Complete Guide to Overcoming Methodological ChallengesChunbao Jiao, Omer Faruk Karakaya, Neda Dadgar, et al.
Journal for Immunotherapy of Cancer|April 11, 2024
Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeuticsYee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, et al.
Frontiers in Oncology|May 24, 2021
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent GlioblastomaJoseph S Durgin, Fraser Henderson, MacLean P Nasrallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteersSawa Ito, Catherine M Bollard, Mattias Carlsten, et al.
Pageof 4